Nagashima Y, Nishihira H, Miyagi Y, Tanaka Y, Sasaki Y, Nishi T, Imaizumi K, Aoki I, Misugi K
Department of Pathology, Yokohama City University School of Medicine, Japan.
Cancer. 1996 Feb 15;77(4):799-804. doi: 10.1002/(sici)1097-0142(19960215)77:4<799::aid-cncr28>3.0.co;2-v.
A candidate tumor suppressor gene, WT-1, is believed to have an important role in the pathogenesis of Wilms' tumor, especially that occurring in patients with congenital aniridia.
To obtain a stable tumor line to work with, Wilms' tumor tissue was serially transplanted in athymic nude mice. Biopsied Wilms' tumor tissue, derived from an aniridia patient, was transplanted subcutaneously to an athymic nude mouse, and then transplanted serially. Histopathologic and molecular biologic studies were performed on the xenotransplants.
The aniridia patient showed partial deletion in one short arm of chromosome 11, which bears the WT-1 gene. The tumor was successfully transplanted in the nude mouse. Although the tumor contained blastemic, organoid, and stromal histologic elements, the organoid element began to decrease after more than 20 passages. Cytogenetic analysis revealed an additional abbreviation of one long arm of chromosome 6. Dot blot analysis showed that the copy number of WT-1 gene was decreased to half the amount in the tumor, in spite of the WT-1 transcript with normal size detected by Northern blotting.
The tumor is expected to bear one WT-1 gene with minute abnormalities as well as one congenitally deleted gene. This tumor line is useful when examining the effect caused by introduction of WT-1 gene to Wilms' tumor in vivo.
候选肿瘤抑制基因WT-1被认为在肾母细胞瘤的发病机制中起重要作用,尤其是在先天性无虹膜患者中发生的肾母细胞瘤。
为了获得一个稳定的可用于研究的肿瘤系,将肾母细胞瘤组织在无胸腺裸鼠中进行连续传代移植。将取自一名无虹膜患者的肾母细胞瘤活检组织皮下移植到一只无胸腺裸鼠体内,然后进行连续移植。对异种移植瘤进行了组织病理学和分子生物学研究。
该无虹膜患者在携带WT-1基因的11号染色体短臂上出现部分缺失。肿瘤在裸鼠中成功移植。虽然肿瘤包含胚性、器官样和间质性组织学成分,但在传代20次以上后,器官样成分开始减少。细胞遗传学分析显示6号染色体长臂出现额外缺失。斑点印迹分析表明,WT-1基因的拷贝数在肿瘤中减少到一半,尽管通过Northern印迹检测到大小正常的WT-1转录本。
预计该肿瘤携带一个有微小异常的WT-1基因以及一个先天性缺失的基因。该肿瘤系在体内研究WT-1基因导入肾母细胞瘤所产生的效应时很有用。